CR-014 (HealthLinx)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameCR-014 (HealthLinx)
Drug Alias NameCR-014 (Cryptome/HealthLinx)CR-014
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionP21-activated kinases inhibitors
TargetsP21-activated kinases
Therapy Area/IndicationsEdemaNervous System DiseasesRespiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Virginia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHealthlinxUniversity Of Virginia
Active IndicationsN/A
Inactive IndicationsEdemaNervous System DiseasesRespiratory Distress Syndrome, Adult

Other Information

ATC CodeN/A
Related LinksN/A